Rokote Laboratories Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 5

Rokote Laboratories General Information

Description

Developer of a nasal spray vaccine designed to protect people against the COVID-19 virus. The company's vaccine is based on gene transfer technology, which uses a safe adenovirus carrier that contains a cloned Deoxyribonucleic acid strand that causes nasopharyngeal cells to produce the virus protein, which, in turn, produces a response to the vaccine, enabling patients to get an immune response.

Contact Information

Website
www.rokote.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Care of Terkko Health Hub
  • Haartmaninkatu 4, Building 14
  • 00290 Helsinki
  • Finland
Primary Industry
Drug Discovery
Vertical(s)
Corporate Office
  • Care of Terkko Health Hub
  • Haartmaninkatu 4, Building 14
  • 00290 Helsinki
  • Finland

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Rokote Laboratories Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC 15-Dec-2022 Completed Clinical Trials - Phase 1
4. Early Stage VC 07-Jul-2021 Completed Clinical Trials - Phase 1
3. Debt - General 07-Jul-2021 Completed Clinical Trials - Phase 1
2. Corporate 02-Sep-2020 Completed Clinical Trials - Phase 1
1. University Spin-Out 01-Jan-2020 Completed Clinical Trials - Phase 1
To view Rokote Laboratories’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Rokote Laboratories Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a nasal spray vaccine designed to protect people against the COVID-19 virus. The company's vaccine is based
Drug Discovery
Helsinki, Finland
7 As of 2026

San Diego, CA
 

San Diego, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Rokote Laboratories Competitors (2)

One of Rokote Laboratories’s 2 competitors is Tioga Pharmaceuticals, a Formerly VC-backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Tioga Pharmaceuticals Formerly VC-backed San Diego, CA
ARS Pharmaceuticals Formerly VC-backed San Diego, CA
You’re viewing 2 of 2 competitors. Get the full list »

Rokote Laboratories Patents

Rokote Laboratories Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025202543-A1 A vaccine composition comprising an adenoviral vector and an adenoviral vector delivery enhancing agent Pending 28-Mar-2024
EP-4701659-A1 A viral vector and a vaccine composition comprising the vector Pending 28-Apr-2023
US-20260284181-A1 A viral vector and a vaccine composition comprising the vector Pending 28-Apr-2023
WO-2024223994-A1 A viral vector and a vaccine composition comprising the vector Inactive 28-Apr-2023 A61K39/12

Rokote Laboratories Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Rokote Laboratories Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
The Finnish Innovation Fund Sitra Venture Capital Minority
Finnish Cultural Foundation Limited Partner Minority
Jenny and Antti Wihuri Foundation Limited Partner Minority
Academy of Finland Corporation Minority
University of Helsinki University
To view Rokote Laboratories’s complete investors history, request access »

Rokote Laboratories FAQs

  • When was Rokote Laboratories founded?

    Rokote Laboratories was founded in 2020.

  • Where is Rokote Laboratories headquartered?

    Rokote Laboratories is headquartered in Helsinki, Finland.

  • What is the size of Rokote Laboratories?

    Rokote Laboratories has 7 total employees.

  • What industry is Rokote Laboratories in?

    Rokote Laboratories’s primary industry is Drug Discovery.

  • Is Rokote Laboratories a private or public company?

    Rokote Laboratories is a Private company.

  • What is Rokote Laboratories’s current revenue?

    The current revenue for Rokote Laboratories is .

  • How much funding has Rokote Laboratories raised over time?

    Rokote Laboratories has raised $10.8M.

  • Who are Rokote Laboratories’s investors?

    The Finnish Innovation Fund Sitra, Finnish Cultural Foundation, Jenny and Antti Wihuri Foundation, Academy of Finland, and University of Helsinki have invested in Rokote Laboratories.

  • Who are Rokote Laboratories’s competitors?

    Tioga Pharmaceuticals and ARS Pharmaceuticals are competitors of Rokote Laboratories.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process